F. Zhang
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Epigenetics and DNA Methylation, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers, Acute Myeloid Leukemia Research
Most-Cited Works
- → Adenovirus-Mediated p14ARF Gene Transfer in Human Mesothelioma Cells(2000)124 cited
- → The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer(2012)39 cited
- → An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation(2013)38 cited
- → Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions(2006)17 cited
- → Suppression of Major Histocompatibility Complex (MHC) Class I and II Mediates Resistance to Anti-PD-1 in Lung Adenocarcinoma Tumors That Can Be Overcome by Radiation Therapy(2016)4 cited
- → MA13.07 Structural Classification of Atypical EGFR Mutations Identifies 4 Major Subgroups with Distinct Patterns of Drug Sensitivity(2021)4 cited
- → P1.14-08 Activity of Poziotinib and Other 2nd-Gen Quinazoline EGFR TKIs in Atypical Exon18 and Acquired Osimertinib Resistance Mutants(2019)
- → P3.03-28 LKB1 Mutation Status is Associated with Poor Radiation Outcome in Patients with Non-Small Cell Lung Cancer(2018)
- → IA30 Investigating and Overcoming Primary Resistance of EGFR and HER2 (ERBB2) Exon 20 Mutant NSCLC(2020)